Table A2.
Subcohort | Clinical Group | Actual Count | Test Class | % Error | Statistics | ||
---|---|---|---|---|---|---|---|
ME/CFS | Control | ||||||
PBMC cell death after 48 h in culture | |||||||
Training | ME/CFS | 46 | 41 | 5 | 10.9 | χ2 | 17.0 |
Control | 25 | 10 | 15 | 40.0 | p | 3.8 × 10−5 | |
TOTAL | 71 | 51 | 20 | 21.2 | Fisher p = 2.1 × 10−5 | ||
Test | ME/CFS | 11 | 11 | 0 | 0 | χ2 | 6.39 |
Control | 8 | 3 | 5 | 37.5 | p | 0.012 | |
TOTAL | 19 | 14 | 5 | 15.8 | Fisher p = 4.8 × 10−3 | ||
Lymphoblast Seahorse respirometry | |||||||
Training | ME/CFS | 37 | 34 | 3 | 8.1 | χ2 | 16.6 |
Control | 17 | 6 | 11 | 35.3 | p | 4.6 × 10−5 | |
TOTAL | 54 | 40 | 14 | 16.6 | Fisher p = 3.1 × 10−5 | ||
Test | ME/CFS | 12 | 10 | 2 | 16.7 | χ2 | 4.22 |
Control | 3 | 0 | 3 | 0.0 | p | 0.04 | |
TOTAL | 15 | 10 | 5 | 13.3 | Fisher p = 0.022 | ||
Lymphoblast TORC1 activity | |||||||
Training | ME/CFS | 34 | 30 | 4 | 11.8 | χ2 | 10.65 |
Control | 19 | 8 | 11 | 42.1 | P | 1.1 × 10−3 | |
TOTAL | 53 | 38 | 15 | 22.6 | Fisher p = 9.1 × 10−4 | ||
Test | ME/CFS | 10 | 9 | 1 | 10.0 | χ2 | 1.59 |
Control | 3 | 1 | 2 | 33.3 | p | 0.21 | |
TOTAL | 13 | 10 | 3 | 15.3 | Fisher p = 0.11 | ||
Combined tests | |||||||
Training | ME/CFS | 22 | 21 | 1 | 4.5 | χ2 | 20.9 |
Control | 11 | 1 | 10 | 9.1 | p | 4.9 × 10−6 | |
TOTAL | 33 | 22 | 11 | 6.1 | Fisher p = 1.3 × 10−6 | ||
Test | ME/CFS | 7 | 6 | 1 | 14.3 | χ2 | 3.35 |
Control | 3 | 0 | 3 | 0.0 | p | 0.067 | |
TOTAL | 10 | 6 | 4 | 10.0 | Fisher p = 0.033 |